Regulatory Science Ireland: bridging the information gap on biosimilar medicines

Research output: Contribution to journalArticlepeer-review

Abstract

Regulatory Science Ireland (RSI) is a voluntary network of interested parties from academia, the Health Products Regulatory Authority (HPRA), pharmaceutical and medical device industries and government agencies. RSI is conducting a research project, the objective of which is to enhance understanding of biosimilar medicines amongst stakeholders and encourage best practice in the use of these medicines.

Original languageEnglish
Pages (from-to)168-170
Number of pages3
JournalGaBI Journal
Volume5
Issue number4
DOIs
Publication statusPublished - 2016

Keywords

  • Biological medicines
  • Biosimilar
  • Health Products Regulatory Authority
  • Regulatory science
  • Regulatory Science Ireland

Cite this